Global Prothrombin Complex Concentrate Market Size By Product (3-Factor PCC And 4-Factor PCC), By Application (Acquired Coagulation Factor Deficiency And Congenital Coagulation Factor Deficiency), By End-Use (Hospitals, Ambulatory Surgical Centers), By Geography Scope And Forecast

Prothrombin Complex Concentrate Market Size And Forecast

Prothrombin Complex Concentrate Market size was valued at USD 0.883 Billion in 2024 and is projected to reach USD 1.918 Billion by 2031 growing at a CAGR of 10.18% from 2024 to 2031.

The Global Prothrombin Complex Concentrate (PCC) Market is expected to showcase substantial growth during the forecasted period with a boost in market demand due to an increased effort in the research and development of PCC products. Owing to high adoption and growing demand for sustainable healthcare, PCC’s revenue share is increasing. The COVID-19 pandemic has seen a rise in plasma-related therapies, increasing the PCC demand rapidly. The Global Prothrombin Complex Concentrate Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Prothrombin Complex Concentrate Market Definition

Prothrombin Complex Concentrate (PCC), also known as factor lX complex, is a medication made up of blood clotting factors ll, lX, and X. Some of the versions also contain factor Vll. It is used to treat and prevent bleeding in hemophilia B is a pure factor lX is not available. It may also be utilized in those with not sufficient of these components due to other reasons such as warfarin treatment.

It is infused into the body through a needle or a syringe into a vein. Common side impacts include allergic reactions, regurgitating, cerebral torments, and sleepiness. It can have some serious negative impacts as well such as blood clots which may result in a heart attack, stroke, pulmonary embolism, and so on.

Global Prothrombin Complex Concentrate Market Overview

PCC promises to have a substantial rise due to its clinical advantage against fresh frozen plasma (FPP). PCC requires less volume and time to infuse with respect to FPP and proves to be more effective. PCC also does not require blood matching and thawing like FPP. These advantages of PCC make it preferable over FPP thus adding to the Market demand for PCC. Recent government regulations and policies also have worked in favor of PCC with some relaxation in its usage approval.

Favorable government funding for PCC is another driving factor for its substantial growth. Owing to COVID-19 and a rise in plasma-related therapies PCC has seen a rapid increase in its demand for various therapies. The high degree of competition and increased procurement costs are some of the factors which could restrain the PCC demand during the forecasted period.

Global Prothrombin Complex Concentrate Market Segmentation Analysis

The Global Prothrombin Complex Concentrate Market is segmented on the Basis of Product, Application, End-Use, and Geography.

Prothrombin Complex Concentrate Market, By Product

• 3-Factor PCC
• 4-Factor PCC
• Others

Based on Product, The market is segmented into 3-Factor PCC, 4-Factor PCC, and Others. 3-Factor PCC contains low levels of factor Vll and 4-Factor PCC contains vitamin K- dependent coagulation factors ll (Fll), Vll (FVll), lX (FlX), and X (FX), and the antithrombotic proteins C and S. The excipients are human antithrombin all, heparin albumin, sodium chloride, and sodium citrate.

Prothrombin Complex Concentrate Market, By Application

• Acquired Coagulation Factor Deficiency
• Congenital Coagulation Factor Deficiency
• Others

Based on Application, The market is segmented into Acquired Coagulation Factor Deficiency, Congenital Coagulation Factor Deficiency, and Others. Acquired Coagulation Factor Deficiency is a scenario where the antibodies inhibit the activity or increase the clearance of the clotting factor. Congenital Coagulation Factor Deficiency refers to an inherited deficiency of coagulation factors in the blood.

Prothrombin Complex Concentrate Market, By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Others

Based on End-Use, The market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. PCC therapy can be conducted at hospitals and surgical centers as well where there is a need accordingly.

Prothrombin Complex Concentrate Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Regional Analysis, The Global Prothrombin Complex Concentrate Market is classified into North America, Europe, Asia Pacific, and the Rest of the world.

Key Players

The “Global Prothrombin Complex Concentrate Market” study report will provide valuable insight with an emphasis on the global market. The major players in the Market are CSL Behring GmBH, Kedrion S.p.A, Octapharma AG, Novo Nordisk, China Biologic Products Holdings Inc., Baxter, Grifols, Shire US Inc., and Kedrion S.p.A. The competitive landscape section also includes key development strategies, Market share, and Market ranking analysis of the above-mentioned players globally.

Key Developments

• In 2021, to develop and manufacture a prothrombin complex that concentrates on treating bleeding disorders, Sanquin and Octapharma entered into a long-term partnership.
• In 2021, to expand its oncology and hematology portfolios, Takeda announced its intention to acquire the biotech company, Maverick Therapeutics.
• In 2020, For its Idelvion product, CSL Behring received FDA approval. This longer-acting factor IX therapy can be used less frequently than conventional prothrombin complex concentrates.
• In 2020, In order to strengthen its regional footprint and broaden its selection of prothrombin complex concentrates products, Grifols constructed a new plasma fractionation facility in China.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Prothrombin Complex Concentrate market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.